Yu Qingqing, Tang Yingchao, Fu Haiyu, Jiang Li, Song Benjing, Wang Wei, Xie Qingyun, Chen Song
College of Medicine, Southwest Jiaotong University, Chengdu Sichuan, 610031, P. R. China.
Department of Orthopedics, the General Hospital of Western Theater Command of Chinese PLA, Chengdu Sichuan, 610083, P. R. China.
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2025 Aug 15;39(8):1045-1050. doi: 10.7507/1002-1892.202505024.
To evaluate the analgesic efficacy of ultrasound-guided high fascia iliaca compartment block (HFICB) in managing tourniquet-related pain following total knee arthroplasty (TKA).
A prospective randomized controlled trial was conducted involving 84 patients with severe knee osteoarthritis or rheumatoid arthritis who underwent unilateral TKA between March 2024 and December 2024. Patients were randomly assigned to two groups ( =42) using a random number table. In the trial group, ultrasound-guided HFICB was performed preoperatively, with 0.2% ropivacaine injected into the fascia iliaca compartment. No intervention was administered in the control group. Baseline characteristics, including gender, age, surgical side, body mass index, and preoperative visual analogue scale (VAS) scores at rest and during movement, showed no significant difference between the two groups ( >0.05). In both groups, a tourniquet was applied after osteotomy and before pulsed lavage, and removed after the closure of the first layer of the joint capsule. Postoperative assessments were conducted at 6, 12, 24, and 48 hours, including VAS scores at the tourniquet site (at rest and during movement), Bromage motor block scores, Ramsay sedation scores, and Bruggrmann comfort scale (BCS) scores to evaluate patient comfort. Additionally, the average tramadol consumption and incidence of nausea and vomiting within 48 hours postoperatively were recorded and compared.
In the trial group and control group, VAS scores during movement at the tourniquet site significantly improved at all postoperative time points compared to preoperative levels ( <0.05). VAS scores at rest increased transiently at 6 hours after operation in both groups, and then gradually decreased to the preoperative level. Except that there was no significant difference at 48 hours after operation in the trial group ( >0.05), there were significant differences at other time points of two groups compared to preoperative score ( <0.05). Except for VAS score at rest at 6 hours, VAS score during movement at 48 hours, and BCS comfort score at 48 hours ( >0.05), the trial group showed significantly better outcomes than the control group in terms of VAS score at rest, VAS score during movement, Ramsay sedation scores, and BCS comfort scores at all other time points ( <0.05). No significant difference was found in Bromage motor block scores between the groups ( >0.05). Tramadol was used in 3 patients in the trial group and 7 patients in the control group within 48 hours after operation, the dosage was (133.30±14.19) mg and (172.40±22.29) mg, showing significant difference ( <0.05). Nausea and vomiting occurred in 4 patients (9.5%) in the trial group and 3 patients (7.1%) in the control group, with no significant difference in incidence between groups ( >0.05).
Ultrasound-guided HFICB provides effective analgesia for tourniquet-related pain following TKA, facilitates early postoperative functional recovery of the knee joint, and may serve as a valuable clinical option for postoperative pain management in TKA patients.
评估超声引导下高位髂筋膜间隙阻滞(HFICB)在全膝关节置换术(TKA)后处理止血带相关疼痛中的镇痛效果。
进行一项前瞻性随机对照试验,纳入84例在2024年3月至2024年12月期间接受单侧TKA的重度膝关节骨关节炎或类风湿关节炎患者。使用随机数字表将患者随机分为两组(每组n = 42)。试验组在术前进行超声引导下的HFICB,将0.2%的罗哌卡因注入髂筋膜间隙。对照组不进行干预。两组的基线特征,包括性别、年龄、手术侧、体重指数以及术前静息和运动时的视觉模拟量表(VAS)评分,差异均无统计学意义(P>0.05)。两组均在截骨后、脉冲冲洗前应用止血带,并在关节囊第一层缝合后移除。术后6、12、24和48小时进行评估,包括止血带部位的VAS评分(静息和运动时)、布罗麻运动阻滞评分、拉姆齐镇静评分和布鲁格曼舒适度量表(BCS)评分,以评估患者的舒适度。此外,记录并比较术后48小时内曲马多的平均消耗量以及恶心和呕吐的发生率。
试验组和对照组中止血带部位运动时的VAS评分在所有术后时间点均较术前水平显著改善(P<0.05)。两组术后6小时静息时的VAS评分均短暂升高,然后逐渐降至术前水平。除试验组术后48小时差异无统计学意义(P>0.05)外,两组其他时间点与术前评分相比差异均有统计学意义(P<0.05)。除6小时静息时的VAS评分、48小时运动时的VAS评分和48小时的BCS舒适度评分外(P>0.05),试验组在所有其他时间点的静息VAS评分、运动VAS评分、拉姆齐镇静评分和BCS舒适度评分方面均显著优于对照组(P<0.05)。两组间布罗麻运动阻滞评分差异无统计学意义(P>0.05)。试验组3例患者和对照组7例患者在术后48小时内使用了曲马多,剂量分别为(133.30±14.19)mg和(172.40±22.29)mg,差异有统计学意义(P<0.05)。试验组4例患者(9.5%)出现恶心和呕吐,对照组3例患者(7.1%)出现恶心和呕吐,两组发生率差异无统计学意义(P>0.05)。
超声引导下的HFICB为TKA后止血带相关疼痛提供了有效的镇痛效果,促进了膝关节术后早期功能恢复,可能是TKA患者术后疼痛管理的一种有价值的临床选择。